Cabungcag, Zhellian .
HRN: 21-73-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2023
CEFTRIAXONE 1G (VIAL)
08/24/2023
08/30/2023
IVTT
1.2grams
Q24h
T/C UTI, T/C Dengue Fever With WS, ARTI
Waiting Final Action
Indication: Empiric Type of Infection: URTIBloodstreamIntra-abdominalMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes